Publications

• Rethinking Poison Pills, Again
  9 April 2020
  Andrew L. Bab
  ,
  Gregory V. Gooding
  ,
  William D. Regner
  ,
  Sergio Torres
  ,
  Sue Meng
• Projecting Performance in the Age of COVID-19
  3 April 2020
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Matthew E. Kaplan
  ,
  Sue Meng
  ,
  William D. Regner
  ,
  Jeffrey J. Rosen
• Present Tense: Allocating the Evolving Risk of COVID-19 in M&A Transactions
  30 March 2020
  Jennifer L. Chu
  ,
  Michael Diz
  ,
  Gregory V. Gooding
  ,
  Sue Meng
  ,
  William D. Regner
  ,
  Kevin Rinker
  ,
  Jeffrey J. Rosen
• Law360: The Advantages Of PE Sponsor-Strategic Partnerships
  19 February 2020
  Law360
  Uri Herzberg
  ,
  Sue Meng
  ,
  Spencer K. Gilbert
  ,
  Alexandra P. Grossman
• The Private Equity Report Fall 2019, Vol 19, No 2
  November 2019
  Andrew L. Bab
  ,
  Uri Herzberg
  ,
  Eric T. Juergens
  ,
  Matthew E. Kaplan
  ,
  Henry Lebowitz
  ,
  Sue Meng
  ,
  Paul M. Rodel
  ,
  Jeffrey E. Ross
  ,
  Scott B. Selinger
  ,
  Patricia Volhard
  ,
  Joshua M. Samit
  ,
  John Young
  ,
  Spencer K. Gilbert
  ,
  Alexandra P. Grossman
  ,
  C. Chloe Orlando
  ,
  Ryan T. Rafferty
  ,
  Nathan Frost
• Unlocking Value through the Use of Sponsor-Strategic Partnerships
  November 2019
  Uri Herzberg
  ,
  Sue Meng
  ,
  Spencer K. Gilbert
  ,
  Alexandra P. Grossman
• Private Equity Guide to Consumer Product Investing Under the Trump Administration: Food and Drug Administration (FDA) Developments
  18 April 2019
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Michael Diz
  ,
  Sue Meng
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Kevin M. Schmidt
  ,
  Melissa B. Runsten
• 2018 Private Equity Midyear Review and Outlook
  9 August 2018
  Jonathan Adler
  ,
  Andrew M. Ahern
  ,
  Catherine Amirfar
  ,
  Christopher Anthony
  ,
  Kenneth J. Berman
  ,
  Andrew J. Ceresney
  ,
  Peter A. Furci
  ,
  Robert B. Kaplan
  ,
  Rafael Kariyev
  ,
  Satish M. Kini
  ,
  Sue Meng
  ,
  David L. Portilla
  ,
  Julie M. Riewe
  ,
  Thomas Smith
  ,
  Patricia Volhard
  ,
  Luke P. Eldridge
  ,
  Felix Paterson
• Getting to an Answer in In Re Answers
  30 April 2014
  Private Funds Management
  Gregory V. Gooding
  ,
  Sue Meng
• “Getting to an Answer in In re Answers”
  Winter 2014, Vol. 14, Number 1
  Gregory V. Gooding
  ,
  Sue Meng
• “Getting to an Answer in In re Answers”
  Winter 2014
  Gregory V. Gooding
  ,
  Sue Meng
• Top-Up Options and Tender Offers: Getting across the Finish Line
  24 October 2011
  Mergers & Acquisitions
  Gregory V. Gooding
  ,
  Sue Meng
• The Private Equity Report
  Spring 2011
  Franci J. Blassberg
  ,
  Michael P. Harrell
  ,
  Satish M. Kini
  ,
  Gregory T. Larkin
  ,
  Lawrence K. Cagney
  ,
  Jonathan F. Lewis
  ,
  Matthew E. Kaplan
  ,
  Gregory V. Gooding
  ,
  Sue Meng
  ,
  Jonathan E. Levitsky
  ,
  Paul D. Brusiloff
  ,
  Elizabeth Pagel Serebransky
  ,
  Maurizio Levi-Minzi
  ,
  E. Drew Dutton
  ,
  Andrew L. Bab
  ,
  Jonathan Adler
  ,
  Anne-Lise Quach
• Running on a Dual Track
  24 February 2011
  The Daily Deal and The Deal
  Paul S. Bird
  ,
  Jonathan E. Levitsky
  ,
  Sue Meng
• The Private Equity Report
  Fall 2010
  Franci J. Blassberg
  ,
  Guy Lewin-Smith
  ,
  Edwin Northover
  ,
  E. Drew Dutton
  ,
  Gary W. Kubek
  ,
  Kyra K. Bromley
  ,
  Marcia L. MacHarg
  ,
  Paul S. Bird
  ,
  Jonathan E. Levitsky
  ,
  Sue Meng
  ,
  Geoffrey Kittredge
  ,
  Mark P. Goodman
  ,
  Erica S. Weisgerber
  ,
  Jeffrey J. Rosen
  ,
  Peter A. Furci